Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Furoate in Persistent Asthma
NCT01159912Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of fluticasone in asthma (3 arms), sponsored by GSK. Primary endpoint: Forced Expiratory Volume in One Second at 24 weeks. Started Jun 2010; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01159912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159912.